Hatchtech is a venture backed private company backed by some of the largest and most influential life sciences investors in Australia:
Oct 21, 2014 Hatchtech Announces Successful Results from Phase 2 Ovicidal Study
Sep 02, 2014 Hatchtech Announces Successful Phase 3 Results
Dec 11, 2013 Hatchtech Receives SPA and Announces Patent Grants
Oct 31, 2013 Hatchtech Completes $12.6m Capital Raise, Secures Funds for Phase III and NDA Submission